𝔖 Bobbio Scriptorium
✦   LIBER   ✦

E46. Clinical and biological implications of epidermal growth factor receptor (EGFR) gene mutations and gefitinib treatment for NSCLC

✍ Scribed by Mitsudomi, Tetsuya


Book ID
118572525
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
38 KB
Volume
49
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of epidermal growth factor recept
✍ Jeeyun Lee; Kee-Taek Jang; Chang-Seok Ki; Taekyu Lim; Young Suk Park; Ho Yeong L πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 477 KB

## Abstract ## BACKGROUND. Erlotinib, in combination with gemcitabine, has shown clinical benefits in pancreatic adenocarcinoma patients. The presence of __EGFR__ mutations and increased __EGFR__ copy numbers in pancreatic adenocarcinoma was explored. ## METHODS. Sixty‐six pancreatic cancer pati